Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
ROCKET PHARMACEUTICALS, INC. (RCKT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/05/2023 |
SC 13D/A
| RTW INVESTMENTS, LP reports a 23% stake in Rocket Pharmaceuticals, Inc. |
| 10/11/2022 |
SC 13D/A
| RTW INVESTMENTS, LP reports a 24.4% stake in Rocket Pharmaceuticals, Inc. |
| 09/21/2022 |
SC 13D/A
| RTW INVESTMENTS, LP reports a 24.6% stake in Rocket Pharmaceuticals, Inc. |
| 08/31/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/29/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/08/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/13/2019 |
SC 13D/A
| RTW INVESTMENTS, LLC reports a 31.9% stake in ROCKET PHARMACEUTICALS, INC. |
| 04/18/2019 |
SC 13D/A
| RTW INVESTMENTS, LLC reports a 33.9% stake in ROCKET PHARMACEUTICALS, INC. |
| 11/29/2018 |
SC 13D/A
| RTW INVESTMENTS, LLC reports a 36.6% stake in ROCKET PHARMACEUTICALS, INC. |
| 01/19/2018 |
SC 13D/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 1.5% stake in Rocket Pharmaceuticals, Inc. |
| 10/26/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/03/2017 |
SC 13D/A
| Care Capital III LLC reports a 2% stake in Inotek Pharmaceuticals Corporation |
| 02/10/2017 |
SC 13D/A
| INOTEK PHARMACEUTICALS CORP reports a 5.6% stake in Inotek Pharmaceuticals Corporation |
| 01/06/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
|
|